Company page

Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. is a public company traded under the ticker APRE in the American market. The company has a market capitalization of approximately $8.85 million. Aprea focuses on developing innovative therapies for cancer treatment.

profileAPRE:NASDAQAI content: aiUpdated June 24, 2026/company/aprea-therapeutics-inc/c-hkbpnycx
Aprea Therapeutics, Inc. logo
Ticker
APRE:NASDAQ
Asset type
Stock
Market cap
$8.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD